Skip to content
BTS Research
  • Services
    • col1
      • In Vitro Services
      • Pharmacology Services
      • Toxicology Services
    • col2
      • IND Process
      • Disease Models
      • Medical Device Testing
    • col3
      • Custom Services
      • Vivarium Space
      • Drug Development Process
      • Histology Services
  • About Us
  • BTS News
  • Animal Species
  • Why BTS
  • Request A Quote
  • Partnering
  • Contact
    • Careers

Archive for May 2025

FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms

May 22, 2025 | 0

The U.S. Food and Drug Administration’s Center for Devices and Radiological Health has issued letters to two third-party medical device testing firms in China. Source: FDA Press Releases

Read More

FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation

May 22, 2025 | 0

The U.S. Food and Drug Administration (FDA) today announced the seizure of nearly two million units of unauthorized e-cigarette products in Chicago, with an estimated retail value of $33.8 million. Source: FDA Press Releases

Read More

FDA takes steps to enhance state importation programs to help lower prescription drug prices

May 21, 2025 | 0

The U.S. Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective and more affordable drugs for American patients, as part of its efforts to implement Executive Order Lowering Drug Prices by Once Again Putting Americans First. Source: FDA Press Releases

Read More

FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

May 16, 2025 | 0

The U.S. Food and Drug Administration cleared the first blood test, which measures two key biomarkers, to aid in diagnosing Alzheimer’s disease in people exhibiting symptoms of the disease. Source: FDA Press Releases

Read More

FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public

May 16, 2025 | 0

FDA’s Commissioner Martin A. Makary, M.D., M.P.H., will lead the inaugural meeting of an independent panel of scientific experts to discuss talc exposure in a public forum on Tuesday, May 20, 2025 at 10 a.m. ET. Source: FDA Press Releases

Read More

FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy

May 15, 2025 | 0

The U.S. Food and Drug Administration today is taking a major step to increase transparency and ensure the safety of chemicals in our food Source: FDA Press Releases

Read More

FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

May 13, 2025 | 0

FDA begins action to remove unapproved fluoride drug products from the market for the well-being of children Source: FDA Press Releases

Read More

HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

May 13, 2025 | 0

Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced the next steps in Operation Stork Speed Source: FDA Press Releases

Read More

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

May 13, 2025 | 0

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers Source: FDA Press Releases

Read More

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program

May 9, 2025 | 0

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program Source: FDA Press Releases

Read More
Older Posts »

Recent Posts

  • FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
  • FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
  • FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
  • FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation
  • FDA takes steps to enhance state importation programs to help lower prescription drug prices

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • October 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • February 2015
  • November 2014
  • May 2014
  • April 2014

Categories

  • BioPharma
  • BTS News
  • Devices & Diagnostics Letter
  • Drug GMP Report
  • Drug Industry Daily
  • FDAnews Device Daily Bulletin
  • FDAnews Drug Daily Bulletin
  • Generic Line
  • International Medical Device Regulatory Monitor
  • International Pharmaceutical Regulatory Monitor
  • News
  • QMN Weekly Bulletin
  • The Food & Drug Letter
  • The GMP Letter
  • Uncategorized
  • Washington Drug Letter

Company

BTS Research
Toll Free: (866) 599-3019
Fax: (858) 605-5916
Email: info@btsresearch.com

PARTNERING

Strategic collaborations are an important part of BTS Research growth. Read More >>

CAREERS

To inquire about careers with BTS Research. Read More >>
  • Services
  • Animal Species
  • About Us
  • Why BTS
  • Request A Quote
  • Contact

Follow Us

Attribution

icons created by Freepik – Flaticon

© 2023 BTS Research
Scroll To Top